Home › Cancro al seno › Minnesota › Plymouth
Studi clinici su Cancro al seno a Plymouth, MN
8 studi su Cancro al seno cercano partecipanti presso sedi a Plymouth e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · a 4 mi di distanza
- Minnesota Oncology - Maple Grove, Maple Grove · a 4 mi di distanza
- Ridgeview Medical Center, Waconia · a 20 mi di distanza
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
In reclutamentoFase 1/2
- Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove · a 4 mi di distanza
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · a 4 mi di distanza
- Minnesota Oncology - Maple Grove, Maple Grove · a 4 mi di distanza
- Ridgeview Medical Center, Waconia · a 20 mi di distanza
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
In reclutamentoFase 2/3
- Minnesota Oncology Hematology, Maple Grove · a 4 mi di distanza
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
In reclutamentoFase 3
- Minnesota Oncology, Maple Grove · a 4 mi di distanza
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
In reclutamentoFase 3
- Minnesota Oncology Hematology, P.A., Plymouth
- Minnesota Oncology Hematology, P.A., Maple Grove · a 4 mi di distanza
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
In reclutamentoFase 3
- Fairview Clinics and Surgery Center Maple Grove, Maple Grove · a 4 mi di distanza
- Ridgeview Medical Center, Waconia · a 20 mi di distanza
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Ridgeview Medical Center, Waconia · a 20 mi di distanza
Studi su Cancro al seno in altre città
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Plymouth
- Cancro colorettale9 studi
- Cancro del polmone non a piccole cellule8 studi
- Cancro ai polmoni7 studi
- Cancro alla prostata6 studi
- Cancro del colon5 studi
- Cancro al rene (carcinoma a cellule renali)5 studi
- Melanoma5 studi
- Cancro dell'endometrio4 studi
- Cancro ovarico4 studi
- Cancro del retto4 studi
- Cancro metastatico4 studi
- Cancro della vescica3 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.